193 related articles for article (PubMed ID: 36088429)
1. UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer.
Cui P; Li H; Wang C; Liu Y; Zhang M; Yin Y; Sun Z; Wang Y; Chen X
J Ovarian Res; 2022 Sep; 15(1):103. PubMed ID: 36088429
[TBL] [Abstract][Full Text] [Related]
2. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
Hao P; Kang B; Li Y; Hao W; Ma F
Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
[TBL] [Abstract][Full Text] [Related]
3. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer.
Huang W; Huang H; Xiao Y; Wang L; Zhang T; Fang X; Xia X
Cell Cycle; 2022 Apr; 21(8):780-791. PubMed ID: 35130130
[TBL] [Abstract][Full Text] [Related]
4. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
Qiao L; Dong C; Ma B
J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway.
Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B
Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593
[TBL] [Abstract][Full Text] [Related]
6. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
[TBL] [Abstract][Full Text] [Related]
7. UBE2T promotes β-catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK-dependent activation.
Lioulia E; Mokos P; Panteris E; Dafou D
Mol Oncol; 2022 Apr; 16(8):1694-1713. PubMed ID: 34614271
[TBL] [Abstract][Full Text] [Related]
8. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
9. Irisin/FNDC5 inhibits the epithelial-mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway.
Zhu T; Zhang W; Zhang Y; Lu E; Liu H; Liu X; Yin S; Zhang P
Arch Gynecol Obstet; 2022 Sep; 306(3):841-850. PubMed ID: 35156135
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
[TBL] [Abstract][Full Text] [Related]
11. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
12. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
14. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
15. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
16. UBE2T knockdown inhibits gastric cancer progression.
Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z
Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
Liu F; Zhu C; Gao P; Zheng S; Li C
Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
[TBL] [Abstract][Full Text] [Related]
19. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
20. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
